XML 82 R30.htm IDEA: XBRL DOCUMENT v3.22.4
Equity-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2022
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Schedule of Equity-based Compensation Expense Categories In Consolidated Statements of Operations and Comprehensive Loss

The Company recorded equity-based compensation in the following expense categories in the consolidated statements of operations and comprehensive income (loss) in 2022 and 2021:

 

 

Year ended December 31,

 

 

 

2022

 

 

2021

 

 

 

(in thousands)

 

Research and development

 

$

11,018

 

 

$

8,914

 

General and administrative

 

 

16,939

 

 

 

15,461

 

Total equity-based compensation

 

$

27,957

 

 

$

24,375

 

Schedule of Assumptions Used to Estimate Fair value The grant date fair value was estimated at the time of grant using the Black-Scholes option-pricing model using the following weighted-average assumptions in 2022 and 2021:

 

 

Year Ended
December 31, 2022

 

Year Ended
December 31, 2021

Risk-free interest rate

 

2.65%

 

1.02%

Expected term (in years)

 

6.0

 

6.0

Expected volatility

 

79.81%

 

76.22%

Expected dividend yield

 

0.00%

 

0.00%

Summary of Stock Options Activity

The following table summarizes 2022 and 2021 stock option activity (shares and aggregate intrinsic value in thousands):

 

 

Number of
   Options

 

 

Weighted-Average Exercise Price

 

 

Weighted-Average Remaining Contractual Term (Years)

 

 

Aggregate Intrinsic Value

 

Outstanding as of December 31, 2020

 

 

4,603

 

 

$

4.30

 

 

 

 

 

 

 

Granted

 

 

5,482

 

 

$

23.82

 

 

 

 

 

 

 

Exercised

 

 

(763

)

 

$

4.30

 

 

 

 

 

 

 

Forfeited

 

 

(63

)

 

$

17.23

 

 

 

 

 

 

 

Outstanding as of December 31, 2021

 

 

9,259

 

 

$

15.77

 

 

 

 

 

 

 

Granted

 

 

2,888

 

 

$

12.96

 

 

 

 

 

 

 

Exercised

 

 

(1,523

)

 

$

4.31

 

 

 

 

 

 

 

Forfeited

 

 

(1,290

)

 

$

13.80

 

 

 

 

 

 

 

Outstanding as of December 31, 2022

 

 

9,334

 

 

$

17.04

 

 

 

8.31

 

 

$

11,526

 

Exercisable as of December 31, 2022

 

 

3,706

 

 

$

15.31

 

 

 

7.32

 

 

$

10,060

 

Summary of Activity Related to RSUs The following table summarizes the activity related to RSUs during 2022 (shares in thousands):

 

 

Number of
   Shares

 

 

Weighted-Average Grant Date Fair Value

 

Outstanding unvested as of December 31, 2021

 

 

 

 

$

 

Granted(1)

 

 

502

 

 

$

13.28

 

Vested

 

 

(46

)

 

$

13.60

 

Forfeited

 

 

(87

)

 

$

13.60

 

Outstanding unvested as of December 31, 2022

 

 

369

 

 

$

13.16

 

 

(1)
The number granted represents the number of shares issuable upon vesting of service-based and market-based RSUs, assuming the Company achieves its corporate stock price metrics at the target achievement level.
Summary of Activity Related to RSAs The following table summarizes the activity related to RSAs during 2022 and 2021 (shares in thousands) as if the prior equity awards were converted to RSAs at the earliest period presented:

 

 

Number of
   Shares

 

 

Weighted-Average Grant Date Fair Value

 

Outstanding unvested as of December 31, 2020

 

 

364

 

 

$

2.04

 

Vested

 

 

(275

)

 

$

1.45

 

Outstanding unvested as of December 31, 2021

 

 

89

 

 

$

3.87

 

Vested

 

 

(46

)

 

$

3.87

 

Forfeited

 

 

(28

)

 

$

3.87

 

Outstanding unvested as of December 31, 2022

 

 

15

 

 

$

3.87

 

Restricted Stock Units (RSUs) [Member]  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Schedule of Assumptions Used to Estimate Fair value

The following table details the assumptions used in the Monte Carlo simulation model used to estimate the fair value of the market-based RSUs granted during 2022:

 

 

Year Ended
December 31, 2022

 

Stock price

 

$

12.98

 

Volatility

 

 

82.5

%

Remaining term (years)

 

 

2.7

 

Risk-free rate

 

 

2.9

%

Expected dividend yield

 

 

0.0